Colorectal Neoplasms: all 5,734 studies
Page 54 of 58. Open to participants first (1,481), then studies with results posted, then the rest; newest registration first within each.
- 5-FU, Folinic Acid and Irinotecan (FOLFIRI) Plus Cetuximab Versus FOLFIRI Plus Bevacizumab in First Line Treatment Colorectal Cancer (CRC)Status unknownNCT00433927Phase 3
- Liver Infusions of Fluorouracil in Treating Patients With Dukes' A, Dukes' B, or Dukes' C Colon Cancer Undergoing SurgeryCompletedNCT00427310Phase 3
- Fluorouracil and Leucovorin and/or Levamisole After Surgery In Treating Patients With Dukes' B Or Dukes' C Colon CancerCompletedNCT00425152Phase 3
- Bevacizumab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By SurgeryCompletedNCT00423696Phase 2
- Safety of Cetuximab and Oxaliplatin/5-FU/FA/Irinotecan in First-Line Treatment of Metastatic Colorectal CancerCompletedNCT00422773Phase 1/2
- Proteomic Analysis of HLA Complex in Solid Cancers: Breast, Ovary, Colon, Rectum, Stomach, and PancreasStatus unknownNCT00419627
- Pattern of Cell Death Following Neoadjuvant Therapy for Metastatic Colon CancerCompletedNCT00414492
- Oxaliplatin, Capecitabine, and Bevacizumab Followed By Surgery and/or Radiofrequency Ablation in Patients With Colorectal CancerWithdrawnNCT00408772Phase 2
- Chemotherapy and Internal Radiation in Treating Patients With Colorectal Cancer That Has Spread to the LiverStatus unknownNCT00408551Phase 2
- Study to Evaluate Progression Free Survival in Cancer Patients With Advanced Colorectal Carcinoma With AMT2003TerminatedNCT00405561Phase 2/3
- A Study of 1018 Immunostimulatory Sequence (ISS) Administered With Irinotecan and Cetuximab to Treat Patients With Previously Treated Metastatic Colorectal CancerTerminatedNCT00403052Phase 1
- TREE-2: Three Regimens of Eloxatin in Advanced Colorectal CancerCompletedNCT00399750Phase 2
- Study to Assess the Effectiveness of a Omega-3 Enriched Supplement on Chemotherapy Tolerance in Colon Cancer PatientsTerminatedNCT00398333Phase 4
- Tailored Treatment in Metastatic Colorectal CancerTerminatedNCT00396487Phase 3
- Adjuvant Xeloda Plus Eloxatin +/- Avastin After Radical Resection of Liver Metastasis of Colorectal CancerTerminatedNCT00394992Phase 3
- Tegafur-Uracil or Observation in Treating Patients With Stage II Colorectal Cancer That Has Been Completely Removed By SurgeryCompletedNCT00392899Phase 3
- Irinotecan With or Without Panitumumab or Cyclosporine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to FluorouracilCompletedNCT00389870Phase 3
- A New Agent GM-CT-01 in Combination With 5-FU, Avastin and Leucovorin in Subjects With Colorectal CancerWithdrawnNCT00388700Phase 2
- A Study of Avastin in Combination With Chemotherapy for Treatment of Colorectal Cancer and Non-Small Cell Lung Cancer (ARIES)CompletedNCT00388206
- Study On Pazopanib When Given With FOLFOX6 (Fluorouracil, Oxaliplatin, Leucovorin) Or CapeOx (Capecitabine, Oxaliplatin)CompletedNCT00387387Phase 1
- Chemoradiation for Locally Advanced and Low Rectal Cancers: Avastin-Capecitabine-Oxaliplatin-Radiation REctal Cancer TrialCompletedNCT00386828Phase 2
- A Phase III Trial Comparing UFT+PSK to UFT+LV in Stage IIB, III Colorectal CancerStatus unknownNCT00385970Phase 3
- Phase 1 Dose Escalation Study of SN2310 Injectable Emulsion in Patients With Advanced Solid TumorsCompletedNCT00385177Phase 1
- ChronoFOLFOX Plus Avastin for Patients With Metastatic Colorectal CancerTerminatedNCT00385021Phase 2
- Reducing Cancer Disparities for American Indians in the Rural Intermountain WestCompletedNCT00380055Not applicable
- Kukui Ahi Navigator Cancer Screening and Treatment Demonstration ProjectCompletedNCT00379782Not applicable
- Combination Chemotherapy in Treating Patients With Resected Colon CancerCompletedNCT00378716Phase 3
- Phase II Study of Bevacizumab, Capecitabine and Oxaliplatin in Colon CancerCompletedNCT00378066Phase 2
- A Telephone-Based Prevention Care Manager in Increasing Screening Rates for Breast Cancer, Cervical Cancer, and Colorectal Cancer in Minority and Low-Income WomenCompletedNCT00376909Phase 2
- Moderate Physical Activity in Helping Patients Recover Physically and Emotionally From Stage II Or Stage III Colorectal CancerCompletedNCT00373022Not applicable
- Printed Education Materials in Patients Who Are Finishing Treatment for Stage I, Stage II, or Stage IIIA Breast Cancer, Colorectal Cancer, Prostate Cancer, or Chest CancerCompletedNCT00372840Not applicable
- A Phase II Study of Cetuximab Plus Irinotecan in Patients With EGFR-detectable Metastatic Colorectal CarcinomaCompletedNCT00362102Phase 2
- SU011248 in Combination With Irinotecan and Cetuximab as a Second Line Regimen for Stage IV Colorectal CancerTerminatedNCT00361244Phase 1/2
- Computerized and Mailed Reminders in Increasing the Rate of Colorectal Cancer Screening in Adults With an Average Risk for Colorectal CancerCompletedNCT00355004Not applicable
- Educational Intervention With or Without Telephone Counseling in Increasing Colorectal Cancer Screening Compliance in Brothers and Sisters of Patients With Colorectal CancerCompletedNCT00352638Phase 3
- Genetics Education: Preparing Physicians for the FutureStatus unknownNCT00349817Not applicable
- Clinical Study of Capecitabine, Oxaliplatin and Bevacizumab in Colorectal CancerCompletedNCT00345761Phase 1/2
- 1stline Study Capecitabine Administered on Continuous Way Plus Oxaliplatin&Bevacizumab Every 2weeks in Metastatic CCR.CompletedNCT00345696Phase 2
- AZD2171 and Standard Combination Chemotherapy in Advanced Non-Small Cell Lung Cancer or Colorectal CancerCompletedNCT00343408Phase 1
- Phase II Trial of RAD001 in Refractory Colorectal CancerCompletedNCT00337545Phase 2
- Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer.Status unknownNCT00337389Phase 3
- Vorinostat and IV Fluorouracil/Leucovorin (5FU/LV) in Patients With Metastatic Colorectal CancerCompletedNCT00336141Phase 1
- Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal CancerActive, not recruitingNCT00335816Phase 2
- Study of Bevacizumab Alone or Combined With Capecitabine and Oxaliplatin as Support Therapy in Metastatic Colorectal Cancer PatientsCompletedNCT00335595Phase 3
- MR Colonography With Fecal Tagging. Barium vs. BariumFerumoxsilCompletedNCT00332943Phase 4
- Nitric Oxide-Releasing Acetylsalicyclic Acid in Preventing Colorectal Cancer in Patients at High Risk of Colorectal CancerCompletedNCT00331786Phase 1
- Coordinated Endoscopic Colorectal Cancer ScreeningCompletedNCT00327457Not applicable
- Phase 2 Study of ABX-EGF (Panitumumab) in Japanese Subjects With M-colorectal CancerCompletedNCT00327119Phase 2
- Elaboration of a Model for Predicting Efficacy of Monoclonal Antibodies (Cetuximab and Bevacizumab) in Patients With Colorectal Cancer and Liver MetastasesTerminatedNCT00327093Phase 4
- Chemoradiation and Endothelial Progenitor Cells in Colorectal CancerCompletedNCT00325871
- FOLFIRI + Bevacizumab With or Without Dalteparin in First Line Treatment of Advanced Colorectal CancerTerminatedNCT00323011Phase 2
- Irinotecan Discontinuation and Reintroduction for Advanced Colorectal CancerTerminatedNCT00320320Phase 2
- Influence of Sulindac and Probiotics on the Development of Pouch Adenomas in Patients With Familial Adenomatous PolyposisStatus unknownNCT00319007Phase 2
- IRIS Followed by mFOLFOX6 or the Reverse Sequence in Advanced Colorectal CancerSuspendedNCT00316745Phase 3
- Phase II Study of Simvastatin Plus Irinotecan, Fluorouracil, and Leucovorin(FOLFIRI) for Metastatic CRCCompletedNCT00313859Phase 2
- Study of Ticilimumab in Patients With Metastatic Colorectal Cancer Whose Disease Had Progressed After TreatmentCompletedNCT00313794Phase 2
- Magnification Narrow Band Imaging Colonoscopy for Hereditary Non-Polyposis Colorectal Cancer SurveillanceCompletedNCT00313755Not applicable
- Sequential Versus Combination Chemotherapy in Advanced Colorectal CarcinomaCompletedNCT00312000Phase 3
- Liposomal SN-38 in Treating Patients With Metastatic Colorectal CancerCompletedNCT00311610Phase 2
- Dendritic Cell Vaccination in Patients With Advanced Colorectal CancerCompletedNCT00311272Phase 2
- A Phase II Study of the Safety and Efficacy of E7820 Plus Cetuximab in Colorectal Cancer, Preceded by a Run-in Study in Advanced Solid TumorsCompletedNCT00309179Phase 2
- Evaluation of the Efficacy of Xaliproden (SR57746A) in Preventing the Neurotoxicity of Oxaliplatin / 5FU/LV Chemotherapy.CompletedNCT00305188Phase 3
- Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal CancerCompletedNCT00303914
- Combination Chemotherapy as First-Line Therapy in Treating Older Patients With Metastatic Colorectal Cancer That Cannot Be Removed By SurgeryCompletedNCT00303771Phase 3
- Irinotecan With or Without Capecitabine as Second-Line Therapy in Treating Older Patients With Progressive, Metastatic Colorectal Cancer That Cannot Be Removed By SurgeryStatus unknownNCT00303745Phase 2
- Preoperative Assessment for Synchronous Carcinoma or Polyps With Magnetic Resonance (MR) ColonographyCompletedNCT00300547Phase 4
- Modelling Internal Hepatic Movement With an External Abdominal MarkerStatus unknownNCT00299299
- Dose Dense Therapy and Bevacizumab in Solid Tumors and Colorectal CancerTerminatedNCT00296062Phase 1
- Liver Transplantation and Metastatic Colo-rectal Cancer.Active, not recruitingNCT00294827Phase 2
- The MAX Study: Mitomycin C, Avastin and Xeloda in Patients With Untreated Metastatic Colorectal CancerCompletedNCT00294359Phase 2/3
- Phase I/II CT 2106 and 5-FU/FA in Colorectal CancerCompletedNCT00291785Phase 1/2
- Early Alimentation Following Colorectal SurgeryStatus unknownNCT00290524Phase 3
- Interaction of Docetaxel and Lonafarnib in Patients With Advanced CancerTerminatedNCT00288444Phase 1
- Safety and Efficacy of Folfox6 + Cetuximab Versus Folfiri +Cetuximab in Patients With Metastatic Colorectal CancerCompletedNCT00286130Phase 2
- High Dose Simplified Folfiri in Advanced Colorectal Cancer: a Multicentre Phase II StudyCompletedNCT00286000Phase 2
- Early Detection of Polyps and Colon Cancer by Fluorescence Imaging - a Dose-finding StudyCompletedNCT00285701Phase 1/2
- Phase I Study of MEDI522 in Patients With Irinotecan-Refractory Advanced Colorectal CancerCompletedNCT00284817Phase 1/2
- Phase II/III Trial of CPT-11/5-FU/l-LV Versus CPT-11/TS-1 as Second Line Chemotherapy of Unresectable Colorectal CancerCompletedNCT00284258Phase 2/3
- Biomarkers in Patients With Rectal Cancer Undergoing Chemotherapy and Radiation TherapyCompletedNCT00280761
- Study of XL999 in Patients With Metastatic Colorectal CancerTerminatedNCT00277303Phase 2
- Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By SurgeryStatus unknownNCT00274872Phase 2/3
- Study of Using Computerized Education to Increase Patients' Confidence in Their Ability to Be Screened for Colon CancerCompletedNCT00273585Phase 3
- XENOX - Evaluation of the Efficacy of Xaliproden in Reducing the Neurotoxicity of the Oxaliplatin + 5-FU/LV ChemotherapyCompletedNCT00272051Phase 3
- Physicians' Health Study IICompletedNCT00270647Not applicable
- Combination Chemotherapy in Treating Patients With Colorectal Cancer and Resectable MetastasesCompletedNCT00268398Phase 3
- Combination Chemotherapy and Radiation Therapy in Treating Patients With Recurrent Metastatic Colorectal CancerCompletedNCT00268333Phase 2
- Optimized Chemotherapy Followed by Maintenance With Bevacizumab With or Without Erlotinib in Treating Patients With Metastatic Colorectal Cancer That Cannot be Removed by Surgery (DREAM)CompletedNCT00265824Phase 3
- Colorectal Cancer Screening Intervention TrialCompletedNCT00265720Not applicable
- Impact of Positron Emission Tomography Imaging Prior to Liver Resection for Colorectal Adenocarcinoma MetastasesCompletedNCT00265356Phase 3
- Evaluation of 2 Resection Strategies of Synchronous Colorectal Cancer MetastasesTerminatedNCT00264979Not applicable
- A Study of ADH300004 in Surgically Resected Primary or Metastatic Colorectal Cancer and Liver Biopsy, or Planned Hepatic ResectionCompletedNCT00264446Phase 1
- Hereditary Nonpolyposis Colorectal Cancer in Taiwan-Related Genetic Study and Clinical ApplicationsStatus unknownNCT00262171
- Effect of TroVax in Patients Having Colorectal Cancer With Liver Metastases RemovedCompletedNCT00259844Phase 2
- Celecoxib, Capecitabine, and Irinotecan in Treating Patients With Recurrent or Metastatic Colorectal CancerCompletedNCT00258232Phase 2
- Cap/Iri Plus Cetuximab Compared to Cap/ox Plus Cetuximab in Patients With Metastatic Colorectal Cancer.CompletedNCT00254137Phase 2
- A Phase II Trial of Modified FOLFOX 6 and Cetuximab in First Line Treatment of Metastatic Colorectal CancerCompletedNCT00251485Phase 2
- First-Line Capecitabine and Cetuximab for Metastatic Colorectal Ca in Elderly PatientsTerminatedNCT00251186Phase 2
- Gene Expression Analysis of Patients With Metastatic Colorectal Cancer Receiving Oxaliplatin Based Chemotherapy RegimenCompletedNCT00250029Not applicable
- Use of Curcumin in the Lower Gastrointestinal Tract in Familial Adenomatous Polyposis PatientsWithdrawnNCT00248053Phase 2
- Hepatic Artery Infusion With OxaliplatinWithdrawnNCT00244348Phase 1/2